• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肉毒杆菌毒素注射治疗神经源性逼尿肌过度活动症。

Botulinum toxin injections for treating neurogenic detrusor overactivity.

作者信息

Bayrak Ömer, Sadioğlu Erkan, Onur Rahmi

机构信息

Department of Urology, Gaziantep University, Gaziantep, Turkey.

Department of Urology, Marmara University, Istanbul, Turkey.

出版信息

Turk J Urol. 2015 Dec;41(4):221-7. doi: 10.5152/tud.2015.25307.

DOI:10.5152/tud.2015.25307
PMID:26623152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4621151/
Abstract

Neurogenic detrusor overactivity (NDO) is a disorder that can cause high intravesical pressure, decreased capacity, decreased bladder compliance, and upper urinary system damage. The current treatment options for NDO are established on the basis of agents that block parasympathetic innervation of the detrusor and inhibit involuntary bladder contractions. Several side effects, such as dryness of mouth, constipation, dyspepsia, changes in visual accommodation, somnolence, and being unable to obtain consistently favorable results, caused by anticholinergic agents, which are frequently used for this purpose, decrease the patient's compliance to treatment. Procedures such as neuromodulation, auto-augmentation, and enterocystoplasty are surgical options, and they could be used as the last alternative. Thus, botulinum toxin (BTX) injections to the detrusor have been commonly performed in recent years and lead to satisfactory results. The mechanism of action of BTX in NDO is based on the principal of smooth muscle relaxation in the bladder by the transient inhibition of neuromuscular nerve signals. The aim is to decrease acetylcholine secretion by blocking presynaptic vesicles in the neuromuscular junction. When studies were evaluated, it was observed that BTX injections to the detrusor muscle are a necessary and effective option in patients with incontinence caused by NDO. This treatment option could be indicated in situations where anticholinergic agents are not effective or could not be tolerated, and it could be a valuable alternative to major surgical treatments. In this review, we evaluated the effectiveness and reliability of BTX in patients with NDO.

摘要

神经源性逼尿肌过度活动(NDO)是一种可导致膀胱内压升高、容量减少、膀胱顺应性降低及上尿路损害的疾病。目前NDO的治疗方案是基于阻断逼尿肌副交感神经支配并抑制膀胱不自主收缩的药物制定的。常用于此目的的抗胆碱能药物会引起口干、便秘、消化不良、视觉调节改变、嗜睡等多种副作用,且无法持续获得良好效果,从而降低了患者的治疗依从性。神经调节、自体膀胱扩大术和肠膀胱扩大术等手术是治疗选择,可作为最后的备选方案。因此,近年来向逼尿肌注射肉毒杆菌毒素(BTX)的操作较为常见且效果令人满意。BTX在NDO中的作用机制基于通过短暂抑制神经肌肉神经信号使膀胱平滑肌松弛的原理。其目的是通过阻断神经肌肉接头处的突触前囊泡来减少乙酰胆碱的分泌。在对相关研究进行评估时发现,向逼尿肌注射BTX对于NDO所致尿失禁患者是一种必要且有效的选择。在抗胆碱能药物无效或无法耐受的情况下可采用这种治疗方法,它可能是主要手术治疗的一种有价值的替代方案。在本综述中,我们评估了BTX对NDO患者的有效性和可靠性。

相似文献

1
Botulinum toxin injections for treating neurogenic detrusor overactivity.肉毒杆菌毒素注射治疗神经源性逼尿肌过度活动症。
Turk J Urol. 2015 Dec;41(4):221-7. doi: 10.5152/tud.2015.25307.
2
Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury.Meta 分析 A 型肉毒毒素膀胱内注射治疗脊髓损伤后神经原性逼尿肌过度活动。
Arch Phys Med Rehabil. 2013 Aug;94(8):1473-81. doi: 10.1016/j.apmr.2013.04.011. Epub 2013 Apr 28.
3
Botulinum toxin for the management of bladder dysfunction.用于治疗膀胱功能障碍的肉毒杆菌毒素。
Drugs. 2006;66(10):1301-18. doi: 10.2165/00003495-200666100-00001.
4
Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?向逼尿肌注射A型肉毒杆菌毒素:一种治疗特发性和神经源性逼尿肌过度活动症的有效方法?
Neurourol Urodyn. 2005;24(3):231-6. doi: 10.1002/nau.20105.
5
Efficacy of abobotulinumtoxinA versus onabotulinumtoxinA for the treatment of refractory neurogenic detrusor overactivity: a systematic review and indirect treatment comparison.阿巴替林毒素 A 与肉毒毒素 A 治疗难治性神经源性逼尿肌过度活动症的疗效比较:系统评价和间接治疗比较。
J Med Econ. 2023 Jan-Dec;26(1):200-207. doi: 10.1080/13696998.2023.2165366.
6
Impairment of sensory afferents by intrathecal administration of botulinum toxin A improves neurogenic detrusor overactivity in chronic spinal cord injured rats.鞘内注射肉毒杆菌毒素A对感觉传入神经的损伤可改善慢性脊髓损伤大鼠的神经源性逼尿肌过度活动。
Exp Neurol. 2016 Nov;285(Pt B):159-166. doi: 10.1016/j.expneurol.2016.05.029. Epub 2016 May 25.
7
The role of botulinum toxin A in treating neurogenic bladder.A型肉毒杆菌毒素在治疗神经源性膀胱中的作用。
Transl Androl Urol. 2016 Feb;5(1):63-71. doi: 10.3978/j.issn.2223-4683.2016.01.10.
8
A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin.特发性逼尿肌过度活动症患者与神经源性逼尿肌过度活动症患者对首次膀胱内注射A型肉毒杆菌毒素反应的比较。
J Urol. 2005 Sep;174(3):984-9. doi: 10.1097/01.ju.0000169480.43557.31.
9
New therapeutic options for refractory neurogenic detrusor overactivity.难治性神经源性逼尿肌过度活动的新治疗选择。
Minerva Urol Nefrol. 2004 Mar;56(1):79-87.
10
Botulinum toxin-type A in the treatment of drug-resistant neurogenic detrusor overactivity secondary to traumatic spinal cord injury.A型肉毒毒素治疗创伤性脊髓损伤继发的耐药性神经源性逼尿肌过度活动症
BJU Int. 2006 Jul;98(1):77-82. doi: 10.1111/j.1464-410X.2006.06192.x.

本文引用的文献

1
Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology.欧洲泌尿外科学会(EAU)神经泌尿学指南摘要。
Eur Urol. 2016 Feb;69(2):324-33. doi: 10.1016/j.eururo.2015.07.071. Epub 2015 Aug 22.
2
Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity.神经原性逼尿肌过度活动所致尿失禁的肉毒毒素 A 按阶段 3 进行的疗效和耐受性研究。
J Urol. 2012 Jun;187(6):2131-9. doi: 10.1016/j.juro.2012.01.125. Epub 2012 Apr 12.
3
Botulinum toxin A for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients.肉毒杆菌毒素 A 治疗多发性硬化症患者的神经原性逼尿肌过度活动。
Int Braz J Urol. 2011 Sep-Oct;37(5):642-8. doi: 10.1590/s1677-55382011000500012.
4
Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.经尿道前列腺切除术治疗良性前列腺增生术后出血的危险因素分析
Eur Urol. 2011 Oct;60(4):742-50. doi: 10.1016/j.eururo.2011.07.002. Epub 2011 Jul 13.
5
Excitatory cholinergic and purinergic signaling in bladder are equally susceptible to botulinum neurotoxin a consistent with co-release of transmitters from efferent fibers.膀胱中的兴奋性胆碱能和嘌呤能信号同样容易受到肉毒杆菌神经毒素 A 的影响,这与传出纤维中递质的共同释放一致。
J Pharmacol Exp Ther. 2010 Sep 1;334(3):1080-6. doi: 10.1124/jpet.110.169342. Epub 2010 Jun 24.
6
Distribution of the high-affinity binding site and intracellular target of botulinum toxin type A in the human bladder.A型肉毒毒素高亲和力结合位点和细胞内靶位在人膀胱中的分布。
Eur Urol. 2010 May;57(5):884-90. doi: 10.1016/j.eururo.2009.12.022. Epub 2009 Dec 30.
7
Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report.推荐使用肉毒杆菌毒素治疗下尿路疾病和盆底功能障碍:欧洲共识报告。
Eur Urol. 2009 Jan;55(1):100-19. doi: 10.1016/j.eururo.2008.09.009. Epub 2008 Sep 17.
8
Botulinum injections for the treatment of bladder symptoms of multiple sclerosis.肉毒杆菌素注射治疗多发性硬化症的膀胱症状。
Ann Neurol. 2007 Nov;62(5):452-7. doi: 10.1002/ana.21209.
9
Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity.肉毒杆菌毒素A注射于逼尿肌、膀胱黏膜下层和膀胱底部治疗特发性逼尿肌过度活动的疗效比较
J Urol. 2007 Oct;178(4 Pt 1):1359-63. doi: 10.1016/j.juro.2007.05.136. Epub 2007 Aug 16.
10
Disparities in the management of multiple sclerosis-related bladder symptoms.多发性硬化症相关膀胱症状管理方面的差异。
Neurology. 2007 Jun 5;68(23):1971-8. doi: 10.1212/01.wnl.0000264416.53077.8b.